BlackRock’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5M | Sell |
10,365,074
-197,635
| -2% | -$351K | ﹤0.01% | 3166 |
|
|
2025
Q4 | $15M | Buy |
10,562,709
+102,723
| +1% | +$150K | ﹤0.01% | 3250 |
|
|
2025
Q3 | $17.2M | Sell |
10,459,986
-279,724
| -3% | -$311K | ﹤0.01% | 3171 |
|
|
2025
Q2 | $7.85M | Sell |
10,739,710
-238,649
| -2% | -$206K | ﹤0.01% | 3545 |
|
|
2025
Q1 | $8.86M | Sell |
10,978,359
-97,556
| -0.9% | -$112K | ﹤0.01% | 3375 |
|
|
2024
Q4 | $15.3M | Sell |
11,075,915
-876,038
| -7% | -$983K | ﹤0.01% | 3202 |
|
|
2024
Q3 | $12.4M | Buy |
11,951,953
+199,453
| +2% | +$274K | ﹤0.01% | 3296 |
|
|
2024
Q2 | $20.3M | Buy |
11,752,500
+521,978
| +5% | +$1.05M | ﹤0.01% | 2975 |
|
|
2024
Q1 | $26.8M | Sell |
11,230,522
-844,173
| -7% | -$2.08M | ﹤0.01% | 2821 |
|
|
2023
Q4 | $40.2M | Buy |
12,074,695
+426,996
| +4% | +$1.14M | ﹤0.01% | 2614 |
|
|
2023
Q3 | $43.6M | Sell |
11,647,699
-4,139,439
| -26% | -$19.1M | ﹤0.01% | 2478 |
|
|
2023
Q2 | $67.4M | Buy |
15,787,138
+1,389,573
| +10% | +$8.2M | ﹤0.01% | 2303 |
|
|
2023
Q1 | $98.5M | Buy |
14,397,565
+315,269
| +2% | +$2.45M | ﹤0.01% | 2027 |
|
|
2022
Q4 | $112M | Buy |
14,082,296
+1,097,453
| +8% | +$8.44M | ﹤0.01% | 1918 |
|
|
2022
Q3 | $125M | Buy |
12,984,843
+101,353
| +0.8% | +$1.03M | ﹤0.01% | 1815 |
|
|
2022
Q2 | $93.3M | Buy |
12,883,490
+811,303
| +7% | +$7.05M | ﹤0.01% | 2053 |
|
|
2022
Q1 | $156M | Buy |
12,072,187
+153,332
| +1% | +$1.95M | ﹤0.01% | 1834 |
|
|
2021
Q4 | $190M | Buy |
11,918,855
+329,012
| +3% | +$5.75M | ﹤0.01% | 1763 |
|
|
2021
Q3 | $186M | Sell |
11,589,843
-430,614
| -4% | -$6.31M | 0.01% | 1769 |
|
|
2021
Q2 | $166M | Buy |
12,020,457
+810,277
| +7% | +$11.5M | ﹤0.01% | 1911 |
|
|
2021
Q1 | $164M | Buy |
11,210,180
+681,830
| +6% | +$11.6M | ﹤0.01% | 1858 |
|
|
2020
Q4 | $183M | Buy |
10,528,350
+317,618
| +3% | +$5.65M | 0.01% | 1687 |
|
|
2020
Q3 | $187M | Sell |
10,210,732
-10,632
| -0.1% | -$198K | 0.01% | 1431 |
|
|
2020
Q2 | $183M | Buy |
10,221,364
+4,768,804
| +87% | +$80.7M | 0.01% | 1431 |
|
|
2020
Q1 | $88.4M | Sell |
5,452,560
-219,659
| -4% | -$4.06M | ﹤0.01% | 1730 |
|
|
2019
Q4 | $102M | Buy |
5,672,219
+386,848
| +7% | +$7.13M | ﹤0.01% | 1947 |
|
|
2019
Q3 | $107M | Buy |
5,285,371
+247,940
| +5% | +$4.95M | ﹤0.01% | 1858 |
|
|
2019
Q2 | $111M | Buy |
5,037,431
+483,541
| +11% | +$8.4M | ﹤0.01% | 1833 |
|
|
2019
Q1 | $62.1M | Sell |
4,553,890
-168,528
| -4% | -$2.25M | ﹤0.01% | 2160 |
|
|
2018
Q4 | $42.7M | Buy |
4,722,418
+94,893
| +2% | +$1.1M | ﹤0.01% | 2332 |
|
|
2018
Q3 | $76.4M | Buy |
4,627,525
+483,443
| +12% | +$8.57M | ﹤0.01% | 2147 |
|
|
2018
Q2 | $58M | Buy |
4,144,082
+810,358
| +24% | +$11.6M | ﹤0.01% | 2278 |
|
|
2018
Q1 | $36.8M | Buy |
3,333,724
+134,998
| +4% | +$1.48M | ﹤0.01% | 2441 |
|
|
2017
Q4 | $28.1M | Sell |
3,198,726
-79,323
| -2% | -$849K | ﹤0.01% | 2608 |
|
|
2017
Q3 | $43.8M | Buy |
3,278,049
+326,468
| +11% | +$4.32M | ﹤0.01% | 2367 |
|
|
2017
Q2 | $42.4M | Buy |
2,951,581
+106,754
| +4% | +$2.05M | ﹤0.01% | 2358 |
|
|
2017
Q1 | $60.2M | Buy |
2,844,827
+2,842,542
| +124,400% | +$69.9M | ﹤0.01% | 2097 |
|
|
2016
Q4 | $64K | Sell |
2,285
-917
| -29% | -$25.7K | ﹤0.01% | 2807 |
|
|
2016
Q3 | $85K | Sell |
3,202
-4,457
| -58% | -$122K | ﹤0.01% | 2698 |
|
|
2016
Q2 | $129K | Buy |
7,659
+6,241
| +440% | +$117K | ﹤0.01% | 2374 |
|
|
2016
Q1 | $30K | Buy |
1,418
+780
| +122% | +$12.8K | ﹤0.01% | 2635 |
|
|
2015
Q4 | $14K | Buy |
638
+100
| +19% | +$2.57K | ﹤0.01% | 2725 |
|
|
2015
Q3 | $11K | Hold |
538
| – | – | ﹤0.01% | 2676 |
|
|
2015
Q2 | $16K | Buy |
+538
| New | +$13.6K | ﹤0.01% | 2499 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG
TCM